Advisory Council for the Elimination of Tuberculosis, 24048 [05-9064]

Download as PDF 24048 Federal Register / Vol. 70, No. 87 / Friday, May 6, 2005 / Notices • TMC was set up in 1998, through a MOH and British government agreement, as a tertiary referral center for HIV/AIDS palliative care. TMC International has a ten-year agreement to manage the center on behalf of the MOH. • TMC has been funded through Cooperative Agreement: U47/ CCU020672 (PA 01142)—Clinical and Laboratory Training in HIV/AIDS in the Republic of Uganda for $1.5 million annually since 2001. • In 2004, TMC received supplemental funding of $1.6 million through The Emergency Plan Track 1.5 to implement the provision of ARVs to more than 1,800 adult and pediatric clients and provide basic preventive care package services to more than 5,000 clients. It is important that patients enrolled in the ART program continue their treatment uninterrupted. • TMC is the only institution in Uganda that has the expertise to conduct training programs for multiple cadres of health care providers in comprehensive holistic rehabilitation and palliative care for PLWHAs in both Uganda and the region. • TMC has demonstrated experience in training health care providers in rural districts within their workstations with practical involvement and support supervision through mobile training teams. TMC has experience producing high quality HIV/AIDS training curricula that are technically accurate and follow solid adult training principles. • TMC has a special focus on pediatrics, with over 2,500 children below 18 years receiving regular care. The center provides specialized training in pediatric HIV/AIDS care. • Currently, the center has over 6,000 active clients with more than 2,000 on ART. C. Funding Approximately $4,500,000 is available in FY 2005 to fund this award. It is expected that the award will begin on or before August 1, 2005, and will be made for a 12-month budget period within a project period of up to 5 years. Funding estimates may change. D. Where To Obtain Additional Information For general comments or questions about this announcement, contact: Technical Information Management, CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341–4146. Telephone: 770–488–2700. For program technical assistance, contact: Jonathan Mermin, MD, MPH, Global Aids Program [GAP], Uganda VerDate jul<14>2003 18:03 May 05, 2005 Jkt 205001 Country Team, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention [CDC], P.O. Box 49, Entebbe, Uganda. Telephone: +256–41320776. E-mail: jhm@cdc.gov. For financial, grants management, or budget assistance, contact: Shirley Wynn, Contract Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341– 4146. Telephone: 770–788–1515. Email: swynn@cdc.gov. Dated: May 2, 2005. William P. Nichols, Director, Procurement and Grants Office, Centers for Disease Control and Prevention. [FR Doc. 05–9065 Filed 5–5–05; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following council meeting. Name: Advisory Council for the Elimination of Tuberculosis (ACET). Times and Dates: 8:30 a.m.–5 p.m., June 8, 2005., 8:30 a.m.–12 p.m., June 9, 2005. Place: Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333. Telephone: (404) 639–8008. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis (TB). Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating TB. Matters To Be Discussed: Agenda items include issues pertaining to TB vaccine, Health Disparities in TB update on QuantiFeron Guidelines, and other TB-related topics. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Paulette Ford-Knights, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., M/S E–07, Atlanta, Georgia 30333, telephone: (404) 639–8008. The Director, Management Analysis and Services Office, has been delegated the Frm 00088 Fmt 4703 Dated: May 2, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–9064 Filed 5–5–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–R–296] DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Sfmt 4703 Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB) Center for Medicare & Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. We are, however, requesting an emergency review of the information collection referenced below. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have submitted to the Office of Management and Budget (OMB) the following requirements for emergency review. We are requesting an emergency review because the collection of this information is needed before the expiration of the normal time limits under OMB’s regulations at 5 CFR Part 1320. This is necessary to ensure compliance with an initiative of the Administration. We cannot reasonably AGENCY: E:\FR\FM\06MYN1.SGM 06MYN1

Agencies

[Federal Register Volume 70, Number 87 (Friday, May 6, 2005)]
[Notices]
[Page 24048]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9064]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following council meeting.

    Name: Advisory Council for the Elimination of Tuberculosis 
(ACET).
    Times and Dates: 8:30 a.m.-5 p.m., June 8, 2005., 8:30 a.m.-12 
p.m., June 9, 2005.
    Place: Corporate Square, Building 8, 1st Floor Conference Room, 
Atlanta, Georgia 30333. Telephone: (404) 639-8008.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis (TB). Specifically, the Council makes recommendations 
regarding policies, strategies, objectives, and priorities; 
addresses the development and application of new technologies; and 
reviews the extent to which progress has been made toward 
eliminating TB.
    Matters To Be Discussed: Agenda items include issues pertaining 
to TB vaccine, Health Disparities in TB update on Quanti-Feron 
Guidelines, and other TB-related topics.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Paulette Ford-Knights, 
National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, 
NE., M/S E-07, Atlanta, Georgia 30333, telephone: (404) 639-8008.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 2, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-9064 Filed 5-5-05; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.